Breast cancer remains the most commonly diagnosed cancer among women in the United States, with over 315,000 new invasive diagnoses expected throughout 2025 and 2026. Five-year survival exceeds 99% when the disease is detectedf at a localized stage, compared to 30-32% at the latter stages, making accurate recognition, timely screening, and precise documentation among the highest-value clinical actions a primary care team can take.
AAVBC’s Breast Cancer Quick Coding Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference spanning risk-stratified screening recommendations, BI-RADS interpretation, ICD-10 and CPT coding, MEAT documentation standards, receptor testing, TNM staging, therapy escalation criteria, and comorbidity management. Grounded in 2024-2026 ACS, USPSTF, ACR, and ACOG guidance, this guide supports consistent, individualized clinical decision-making, helping care teams identify breast cancer earlier, document clinical complexity accurately, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of breast cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Breast cancer remains the most commonly diagnosed cancer among women in the United States, with over 315,000 new invasive diagnoses expected throughout 2025 and 2026. Five-year survival exceeds 99% when the disease is detectedf at a localized stage, compared to 30-32% at the latter stages, making accurate recognition, timely screening, and precise documentation among the highest-value clinical actions a primary care team can take.
AAVBC’s Breast Cancer Quick Coding Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference spanning risk-stratified screening recommendations, BI-RADS interpretation, ICD-10 and CPT coding, MEAT documentation standards, receptor testing, TNM staging, therapy escalation criteria, and comorbidity management. Grounded in 2024-2026 ACS, USPSTF, ACR, and ACOG guidance, this guide supports consistent, individualized clinical decision-making, helping care teams identify breast cancer earlier, document clinical complexity accurately, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of breast cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
